Scientists Find Gene
Clue to Prostate Cancer
SOME men may be genetically
more prone to the harmful effects of cancer-causing agents, according to
a study published in the British Journal of Cancer today* (Tuesday).
US researchers looked at variations
in a gene that controls the body's response to carcinogens and hormones natural
to the body. They found men with prostate cancer often had a different version
of the gene than men who were not affected by the disease.
Scientists believe their findings
may hold important clues in understanding what environmental factors may trigger
the development of prostate cancer and why some men are more susceptible to
the disease than others.
Prostate cancer is the most
common cancer in men but the cause of the disease remains a mystery. Variations
in incidence rates around the world suggest that environmental factors, as
well as genetic differences, may increase the risk of the disease. The high
rates of the disease found in developed countries, for example, has been
linked to the western diet, particularly its high animal fat content. Other
environmental factors that may increase the risk of the disease include, low
dietary intake of selenium and exposure to radiation or a chemical called
cadmium.
Dr Jianfeng Xu, from the Wake
Forest University School of Medicine in North Carolina, says: "Previous research
suggests prostate cancer arises in certain individuals due to a combination
of genetic and environmental factors. Our study suggests that the genetic
make-up of some men leaves them more susceptible to potential carcinogens
in the environment or hormones in the body that could trigger the disease."
Dr Xu and his team, in collaboration
with Dr William Issac's team at Johns Hopkins University, analysed a gene
called CYP1B1, which is thought to play an important role in the development
of cancer.
Previous research has suggested
certain variations in the gene may increase the risk of smoking-related head
and neck cancer, bowel, breast and ovarian cancers.
CYP1B1 normally plays a dual
role in the body, and therefore has been suggested to both cause cancer and
prevent it. The gene helps the body eliminate environmental chemicals that
can cause cancer but can also activate some hormones, turning them into cancer
causing agents. This could be particularly relevant to prostate cancer because
its development is strongly dependent on hormones such as testosterone.
Researchers think tiny variations
in the gene alter its function, with some increasing the cancer causing effects
of the gene and others enhancing its ability to prevent cancer.
The team looked separately
at 13 variations in CYP1B1 and clusters of these variations commonly found
in Caucasian male populations. They compared their frequency in 160 Caucasian
men who had inherited prostate cancer, 250 prostate cancer patients without
a family history and 220 who did not have the disease.
They found that one cluster
of variations in the gene was more common in men with prostate cancer who
had no family history of the disease, while another combination appeared
more frequently in men who did not have the disease.
Based on this study, scientists
now have preliminary evidence that a particular version of the CYP1B1 gene
increases the risk of prostate cancer. This information will help them better
understand how changes in the gene alter its dual functions in the body,
and find ways to stop its cancer causing effects.
Dr Xu says: "This study suggests
men with a particular gene variant have an increased risk of prostate cancer.
It's an exciting finding because we know the gene interacts with certain
cancer-causing chemicals - studying this more closely will bring us closer
to finding out what factors in the environment or within the body may trigger
the disease."
Professor Alex Markham, Chief
Executive of Cancer Research UK, which owns the British Journal of Cancer,
says: "Prostate cancer is the commonest cancer in men in the UK, but currently
little is known about what causes the disease.
"It's important to find out
how genetic and environmental factors combine to cause prostate cancer as,
in the future, this will allow us to identify people at high-risk and advise
them on ways to prevent the disease."
*British
Journal of Cancer Volume 89; Issue 8